Gemcitabine and haemoglobin decreased Patient Reports February 11, 2012

Gemcitabine Side Effects Report #4635732-3
Gemcitabine side effect was reported by a Physician from on Mar 23, 2005. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with urinary tract neoplasm and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemorrhage, neutropenic sepsis, thrombocythaemia, vascular occlusion. Gemcitabine dosage: 1720 MG. During the same period patient was treated with PACLITAXEL, CISPLATIN, ONDANSETRON, CHLORPHENAMINE, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Gemcitabine Side Effects Report #4664946-1
Gemcitabine side effect was reported by a Physician from on May 04, 2005. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with transitional cell carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenic sepsis, thrombocythaemia, thrombosis. Gemcitabine dosage: 1720 MG. During the same period patient was treated with PACLITAXEL, CISPLATIN, ONDANSETRON, CHLORPHENAMINE, DEXAMETHASONE, METOCLOPRAMIDE, ASPIRIN, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Gemcitabine Side Effects Report #5308407-5
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 61 years of age, weighting 124.8 lb, was diagnosed with t-cell lymphoma refractory and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, haematocrit decreased, haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1280 MG DAYS 1 + 8 IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient recovered.

Gemcitabine Side Effects Report #4765583-0
Gemcitabine side effect was reported by a Consumer or non-health professional from DENMARK on Aug 24, 2005. Male patient, 55 years of age, weighting 163.1 lb, was diagnosed with prostate cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count increased, retinal vein occlusion, retinal vein thrombosis. Gemcitabine dosage: 600 MG/M2/2 OTHER. During the same period patient was treated with TAXOTERE, PREDNISOLONE. Patient recovered.


Gemcitabine Side Effects Report #5393659-6
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, 75 years of age, weighting 180.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: atrial fibrillation , haemoglobin decreased, heart rate increased, pulmonary embolism , renal failure acute. Gemcitabine dosage: unknown. During the same period patient was treated with LAPATINIB. Patient died on 07/13/2007.

Gemcitabine Side Effects Report #5696200-3
Gemcitabine side effect was reported by a Health Professional from BELGIUM on Apr 03, 2008. Female patient, 59 years of age, weighting 142.2 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, melaena, pulmonary embolism . Gemcitabine dosage: 1000 MG/M**2 QW IV. During the same period patient was treated with PANTOPRAZOLE, EPREX, ATENOLOL, MOTILIUM, ZOLPIDEM, TRADONAL, POTASSIUM GLUCONATE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4548618-X
Gemcitabine side effect was reported by a Health Professional from on Jan 07, 2005. Male patient, 76 years of age, weighting 196.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood sodium decreased, cardiac failure congestive, cardiomegaly, ejection fraction decreased, fibrosis, haemoglobin decreased, hypokinesia, pneumonia . Gemcitabine dosage: 1500 MG/M2 IV OVER 150 MIN Q WK X 3 WKS FOLLOWED BY 1 WEEK REST. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4846014-9
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2005. Male patient, 58 years of age, weighting 213.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, gastric varices, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, melaena. Gemcitabine dosage: 1000 MG/M2 DAY 1 + 15 IV DRIP. During the same period patient was treated with BEVACIZUMB, CISPLATIN, NORVASC, ARANESP, GLYBURIDE, FISH OIL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5154732-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2006. Male patient, weighting 177.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, gastric varices haemorrhage, gastritis erosive, haematemesis, haematocrit decreased, haemoglobin decreased, varices oesophageal. Gemcitabine dosage: 1000MG/M2 EVERY OTHER WEEK. During the same period patient was treated with CISPLATIN BM, BEVACIZUMAB. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #5986032-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Male patient, weighting 180.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: back pain , blood pressure systolic increased, cardiac failure congestive, disease progression, haemoglobin decreased, hypertension, muscle spasms, nausea . Gemcitabine dosage: 1000 MG/M2 DAY 1, DAY 15 IV DRIP. During the same period patient was treated with BEVACIZUMAB GENENTECH, AMLODEPINE, HYDRALAZINE, CLONIDINE, LEVOTHYROXINE, FUROSENIDE, ENOXAPARIN, SKELAXIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #6028169-6
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Dec 31, 2008. Male patient, weighting 159.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, pyrexia. Gemcitabine dosage: unknown. During the same period patient was treated with TARCEVA, RADIATION, SPIROALDACTONE, REGLAN, COLACE, ZOFRAN, COMPAZINE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #6071592-4
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2009. Male patient, weighting 158.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: asthenia, blood urea increased, dehydration, gastrointestinal haemorrhage, haemoglobin decreased, ill-defined disorder, platelet count increased, white blood cell count increased. Gemcitabine dosage: unknown. During the same period patient was treated with TARCEVA, RADIATION. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4724327-9
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2005. Male patient, weighting 170.4 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dizziness , faeces discoloured, fall , fatigue, gastric ulcer, haemoglobin decreased, haemorrhage, influenza like illness, myalgia. Gemcitabine dosage: 1000MG/M IV DAYS 1,8,15 Q28 DAYS. During the same period patient was treated with COUMADIN. Patient recovered.

Gemcitabine Side Effects Report #4761103-5
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2005. Male patient, weighting 142.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: duodenitis, gastritis, haemoglobin decreased, muscular weakness, upper gastrointestinal haemorrhage. Gemcitabine dosage: unknown. During the same period patient was treated with RADIATION. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4773150-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2005. Male patient, weighting 146.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haematemesis, haematochezia, haemoglobin decreased, radiation injury, rectal haemorrhage. Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4981693-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2006. Male patient, weighting 185.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, blood potassium decreased, cough, dyspnoea, haemoglobin decreased, lung infiltration, lymphocyte percentage decreased, oedema peripheral, post procedural complication. Gemcitabine dosage: 5180 MG. During the same period patient was treated with ARANESP, ATIVAN, LASIX, OXYCODONE, PRILOSEC. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4611058-9
Gemcitabine side effect was reported by a Health Professional from on Mar 15, 2005. Female patient, 72 years of age, weighting 164.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1000 MG/M2 D1,8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4636192-9
Gemcitabine side effect was reported by a Health Professional from on Apr 13, 2005. Female patient, 72 years of age, weighting 164.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1000 MG/M2 D1, 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4638546-3
Gemcitabine side effect was reported by a Health Professional from on Apr 14, 2005. Female patient, 72 years of age, weighting 164.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1000 MG/M2 IV D1, 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4643418-4
Gemcitabine side effect was reported by a Health Professional from on Apr 20, 2005. Female patient, 72 years of age, weighting 164.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1000 MG/M2 IV D1, 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5176734-0
Gemcitabine side effect was reported by a Physician from FRANCE on Dec 04, 2006. Female patient, 68 years of age, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood pressure increased, disease progression, haemoglobin decreased, neoplasm progression, pulmonary oedema, thrombotic microangiopathy. Gemcitabine dosage: unknown. Patient died.

Gemcitabine Side Effects Report #4596047-5
Gemcitabine side effect was reported by a Physician from on Feb 03, 2005. Female patient, 65 years of age, was diagnosed with ovarian cancer, peritoneal carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: body temperature increased, circulatory collapse, gingivitis, haemoglobin decreased, hypovolaemia, nausea , neutropenia, oral intake reduced, stomatitis. Gemcitabine dosage: 1672 MG. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, WARFARIN, ATORVASTATIN, CITALOPRAM HYDROBROMIDE, SANDO K, ATENOLOL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4655819-9
Gemcitabine side effect was reported by a Health Professional from on May 06, 2005. Female patient, 47 years of age, weighting 116.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2 D1 + 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4746475-X
Gemcitabine side effect was reported by a Physician from CHINA on July 29, 2005. Male patient, 61 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: candidiasis, haemoglobin decreased, lung infection, lung neoplasm malignant, metastases to lymph nodes, metastases to pleura, platelet count decreased, productive cough, rales. Gemcitabine dosage: 1000 MG/M2/2 OTHER. During the same period patient was treated with CARBOPLATIN, RIBONUCLEIC ACID. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4869735-0
Gemcitabine side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Male patient, 82 years of age, weighting 125.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection , pneumonia , white blood cell count decreased. Gemcitabine dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, NORVASC, LIPITOR, VITAMINS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4871481-4
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Dec 13, 2005. Male patient, 82 years of age, weighting 125.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, muscular weakness, pneumonia . Gemcitabine dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, NORVASC, LIPITOR, VITAMINS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4705583-X
Gemcitabine side effect was reported by a Consumer or non-health professional from on Aug 27, 2004. Female patient, 73 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood pressure decreased, bronchopneumonia, haemoglobin decreased, heart rate increased, nausea , oxygen saturation decreased, pco2 decreased, platelet count decreased, pneumonitis. Gemcitabine dosage: 1900 MG/DAY IV. During the same period patient was treated with GLUCAZIDE, METFORMIN, ENALAPRIL MALEATE, NIFEDIPINE, ASPIRIN, LEVOFLOXACIN. Patient was hospitalized. Patient died on 12/27/2003.

Gemcitabine Side Effects Report #4807061-6
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on July 07, 2005. Male patient, 72 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemoptysis, red blood cell count decreased, white blood cell count increased. Gemcitabine dosage: 1580 MG/4 OTHER. During the same period patient was treated with CARBOPLATIN, ZOFRAN, ULCERMIN, CODEIN, ONDANSETRON, TRANSAMIN. Patient recovered.

Gemcitabine Side Effects Report #4831118-7
Gemcitabine side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Oct 28, 2005. Male patient, 72 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: bronchial disorder, condition aggravated, haemoglobin decreased, haemoptysis, mass, red blood cell count decreased, white blood cell count increased. Gemcitabine dosage: 1580 MG/4 OTHER. During the same period patient was treated with CARBOPLATIN, ZOFRAN, ULCERMIN, CODEIN, ONDANSETRON, TRANSAMIN. Patient recovered.


Gemcitabine Side Effects Report #4919381-5
Gemcitabine side effect was reported by a Physician from SPAIN on Feb 02, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood potassium increased, blood sodium increased, haematocrit decreased, haemoglobin decreased, hepatic failure, liver disorder, lymphocyte count decreased. Gemcitabine dosage: 2145 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, OMEPRAZOLE, PREDNISONE, CODEINE, FOLIC ACIDI. Patient was hospitalized. Patient died on 12/28/2005.

Gemcitabine Side Effects Report #4715456-4
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 15, 2005. Female patient, 68 years of age, weighting 161.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haematuria, haemoglobin decreased, neutrophil count decreased, platelet count decreased. Gemcitabine dosage: 100 MG /M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4545541-1
Gemcitabine side effect was reported by a Physician from on Dec 14, 2004. Male patient, 62 years of age, weighting 17.64 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: duodenal ulcer, gastric disorder, gastric outlet obstruction, haemoglobin decreased, metaplasia, oesophagitis ulcerative, platelet count decreased. Gemcitabine dosage: 1000 MG/M2 OTHER. During the same period patient was treated with PACLITAXEL, FOLIC ACID, CALCIUM GLUCONATE, ACETYLSALICYLIC ACID SRT, COLACE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4883056-1
Gemcitabine side effect was reported by a Physician from SWITZERLAND on Nov 22, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood sodium decreased, brain natriuretic peptide increased, c-reactive protein increased, capillary leak syndrome, dyspnoea, face oedema, haemoglobin decreased, oedema peripheral. Gemcitabine dosage: unknown. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, PRAVASTATIN, NEXIUM, FOLIC ACID, VITAMIN B12. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4891945-7
Gemcitabine side effect was reported by a Health Professional from HONG KONG on Dec 20, 2005. Male patient, 52 years of age, weighting 124.8 lb, was diagnosed with nasopharyngeal cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, platelet count decreased, pulmonary haemorrhage. Gemcitabine dosage: 2012 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4828119-1
Gemcitabine side effect was reported by a Physician from GERMANY on Nov 04, 2005. Male patient, 88 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, cardiac failure, haematocrit decreased, haemoglobin decreased. Gemcitabine dosage: unknown. During the same period patient was treated with LASIX, PANTOPRAZOLE, FABAHISTIN, BETAHISTINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4830721-8
Gemcitabine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 09, 2005. Male patient, 88 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , aspartate aminotransferase increased, cardiac failure, haematocrit decreased, haemoglobin decreased, pleural disorder . Gemcitabine dosage: unknown. During the same period patient was treated with LASIX, PANTOPRAZOLE, BETAHISTINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4928133-1
Gemcitabine side effect was reported by a Physician from GERMANY on Feb 14, 2006. Male patient, 57 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, pneumonia , red blood cell count decreased, white blood cell count decreased. Gemcitabine dosage: 2100 MG 1X PER 1 WK INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4600311-0
Gemcitabine side effect was reported by a Physician from on Feb 15, 2005. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with malignant urinary tract neoplasm and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: condition aggravated, eye disorder, haemoglobin decreased, neutropenic sepsis, platelet count increased, vascular occlusion, visual acuity reduced. Gemcitabine dosage: 1720 MG. During the same period patient was treated with PACLITAXEL, CISPLATIN, ONDANSETRON, CHLORPHENAMINE, DEXAMETHASONE, METOCLOPRAMIDE, ASPIRIN, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Gemcitabine Side Effects Report #4629671-1
Gemcitabine side effect was reported by a Physician from on Mar 23, 2005. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with malignant urinary tract neoplasm and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: condition aggravated, fundoscopy abnormal, haemoglobin decreased, haemorrhage, neutropenic sepsis, thrombocythaemia, visual acuity reduced, white blood cell count decreased. Gemcitabine dosage: 1720 MG. During the same period patient was treated with PACLITAXEL, CISPLATIN, ONDANSETRON, CHLORPHENAMINE, DEXAMETHASONE, METOCLOPRAMIDE, ASPIRIN, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.


Gemcitabine Side Effects Report #5092008-0
Gemcitabine side effect was reported by a Physician from SPAIN on Aug 09, 2006. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, depressed level of consciousness, dyspnoea, haemoglobin decreased, international normalised ratio increased, platelet count decreased, prothrombin time shortened. Gemcitabine dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, FOLIC ACID, OPTOVITE B, ENALAPRIL, INSULATARD NOVOLET, DIANBEN, DIGOXIN, CARVEDILOL. Patient died on 05/11/2006.

Gemcitabine Side Effects Report #5167762-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Female patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: body temperature decreased, constipation , fatigue, febrile neutropenia, haemoglobin decreased, herpes virus infection, herpes zoster, keratitis interstitial, malaise. Gemcitabine dosage: 2070 MG. During the same period patient was treated with AVASTIN, TAGAMET, ADVAIR DISKUS, PREMARIN, FOLIC ACID, AMBIEN, KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4827609-5
Gemcitabine side effect was reported by a Physician from UNITED STATES on Nov 02, 2005. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal abscess, blood creatinine decreased, blood urea increased, colitis ischaemic, diarrhoea haemorrhagic, epistaxis, extradural abscess, haemoglobin decreased, neutropenia. Gemcitabine dosage: 1250 MG/M2 OTHER. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, ATIVAN, DURAGESIC. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5054549-1
Gemcitabine side effect was reported by a Physician from TURKEY on Apr 14, 2006. Male patient, 52 years of age, weighting 147.7 lb, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, febrile neutropenia, haemoglobin decreased, hypotension, lung infiltration, oxygen saturation decreased, sepsis , tachycardia. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 12/16/2005.

Gemcitabine Side Effects Report #4994338-7
Gemcitabine side effect was reported by a Health Professional from TURKEY on Apr 14, 2006. Male patient, 52 years of age, weighting 147.7 lb, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, sepsis , white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 12/16/2005.

Gemcitabine Side Effects Report #5755266-2
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on May 29, 2008. Male patient, 60 years of age, weighting 169.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Gemcitabine dosage: 1125 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, GABAPENTIN, MINOCYCLINE, LEXAPRO, SENNA, LIPITOR. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5771927-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, 60 years of age, weighting 169.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood creatine increased, haemoglobin decreased, white blood cell count decreased. Gemcitabine dosage: 1125 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, GABAPENTIN, MINOCYCLINE, LEXAPRO, SENNA, LIPITOR. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5805731-4
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 08, 2008. Male patient, 60 years of age, weighting 176.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Gemcitabine dosage: 750 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, GABAPENTIN, LEXAPRO, SENNA, LIPITOR, NEXIUM, TOPROL, HYDRALAZINE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5297817-0
Gemcitabine side effect was reported by a Physician from UNITED STATES on Apr 13, 2007. Female patient, weighting 176.6 lb, was diagnosed with cervix carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain lower, chills, cough, flatulence, haemoglobin decreased, heart rate increased, pharyngolaryngeal pain, pyrexia. Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4762180-8
Gemcitabine side effect was reported by a Physician from UNITED STATES on Sept 06, 2005. Female patient, weighting 136.0 lb, was diagnosed with cervix carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Gemcitabine dosage: 546 MG Q WK, IV. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4900817-0
Gemcitabine side effect was reported by a Physician from SWEDEN on Jan 10, 2006. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with breast cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, epistaxis, fatigue, haemoglobin decreased, neutrophil count decreased, pyrexia, thrombocytopenia, white blood cell count decreased. Gemcitabine dosage: MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4719464-9
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 30, 2005. Female patient, 49 years of age, weighting 220.5 lb, was diagnosed with breast cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cellulitis , disease recurrence, erythema nodosum, haemoglobin decreased, pyrexia, rash . Gemcitabine dosage: 1250 MG/M2. During the same period patient was treated with HERCEPTIN, AREDIA, ARANESP, XANAX, LOPRESSOR. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4831016-9
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 03, 2005. Female patient, 72 years of age, weighting 147.7 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: breast cancer female, disease progression, haemoglobin decreased, neuropathy peripheral, platelet count increased. Gemcitabine dosage: 2000 MG/6 OTHER. Patient recovered.

Gemcitabine Side Effects Report #5113297-X
Gemcitabine side effect was reported by a Physician from UNITED STATES on Aug 31, 2006. Female patient, 60 years of age, weighting 169.8 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood pressure increased, cellulitis , diarrhoea, erythema marginatum, haemoglobin decreased, hyperglycaemia. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, MEDROL ACETATE, CLINDAMYCIN, COMBIVENT, RELAFEN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4964327-7
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on Mar 14, 2006. Female patient, 56 years of age, weighting 147.9 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: breast cellulitis, breast tenderness, erythema, haemoglobin decreased, infection , neutrophil count decreased, pyrexia, urinary tract infection , white blood cell count decreased. Gemcitabine dosage: 2204 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, EPIRUBICIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5059850-3
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on June 29, 2006. Female patient, 41 years of age, weighting 119.0 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, c-reactive protein increased, haemoglobin decreased, tonsillitis, white blood cell count increased. Gemcitabine dosage: 3000 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, ONDANSETRON, DEXAMETHASONE, RANITIDINE, CHLORPHENAMINE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5117501-3
Gemcitabine side effect was reported by a Physician from GERMANY on Sept 07, 2006. Female patient, weighting 167.6 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, menorrhagia, ovarian cancer. Gemcitabine dosage: 1900 MG, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, DEXAMETHASONE, ZOFRAN, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4926221-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Female patient, weighting 279.5 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, fatigue, haemoglobin decreased. Gemcitabine dosage: 2800 MG. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5826222-0
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on July 03, 2008. Male patient, 72 years of age, weighting 157.6 lb, was diagnosed with bladder cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenic sepsis, retinal disorder , retinal ischaemia, retinal vein occlusion, thrombocythaemia, vision blurred, white blood cell count decreased. Gemcitabine dosage: 1720 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, CISPLATIN, ONDANSETRON, CHLORPHENIRAMINE MALEATE, DEXAMETHASONE, METOCLOPRAMIDE, ASPIRIN, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Gemcitabine Side Effects Report #5716021-2
Gemcitabine side effect was reported by a Physician from JAPAN on Apr 16, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, hepatitis b , pain , gastritis, prophylaxis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malignant neoplasm progression, pneumonia , pulmonary embolism , tumour lysis syndrome. Gemcitabine dosage: 1460 MG, UNK. During the same period patient was treated with ANTIVIRALS NOS, LOXONIN, MUCOSTA, NOVAMIN, MAGMITT, OXYCONTIN, OMEPRAL. Patient died on 03/25/2008.


Gemcitabine Side Effects Report #5619515-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Female patient, weighting 124.3 lb, was diagnosed with angioimmunoblastic t-cell lymphoma recurrent and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood culture positive, haemoglobin decreased, neutropenia, pyrexia. Gemcitabine dosage: 1280 MG DAYS 1 AND 8 IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5042657-0
Gemcitabine side effect was reported by a Physician from UNITED STATES on June 28, 2006. Male patient, 80 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: fall , gastrointestinal haemorrhage, haemoglobin decreased, resuscitation. Gemcitabine dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN. Patient was hospitalized. Patient died on 11/14/2005.

Gemcitabine Side Effects Report #4738603-7
Gemcitabine side effect was reported by a Physician from UNITED STATES on July 13, 2005. Male patient, 83 years of age, weighting 143.3 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: arrhythmia , dehydration, diarrhoea, electrocardiogram t wave abnormal, electrolyte imbalance, haematocrit decreased, haemoglobin decreased, hypotension, sepsis syndrome. Gemcitabine dosage: 1000 MG/M2 OTHER. During the same period patient was treated with CPT, MS CONTIN, NEXIUM, HYDROCODONE, SYNTHROID, COSOPT, TRAVANTAN, LORCET. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5122120-9
Gemcitabine side effect was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Male patient, 66 years of age, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dry skin, epistaxis, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, platelet count decreased, swelling, white blood cell count decreased. Gemcitabine dosage: 2200MG IV. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4853692-7
Gemcitabine side effect was reported by a Physician from HONG KONG on Nov 21, 2005. Male patient, 52 years of age, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, platelet count decreased. Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5289385-4
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 04, 2007. Female patient, weighting 164.9 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, hypoxia. Gemcitabine dosage: 1440 MG D1, D8 IV. During the same period patient was treated with CAPECITABINE, NEXIUM, LEXAPRO, PREMARIN, AMARYL, ADVIL, TYLENOL, NORVASC. Patient recovered.